Complete Regulatory & Dossier Support Full CTD dossiers, COA, MSDS, and stability studies provided
However, to date, there is only one randomized clinical trial of GLP-1 RAs (the ELIXA study) evaluating major cardiovascular events as their primary outcomes, and in this study, a neutral cardiovascular effect of lixisenatide was observed in high-risk diabetic subjects
Any significant alteration in your menstrual flow warrants attention, especially if it's coupled with discomfort or an irregular pattern
Unlike the well-known GLP-1 receptor agonists weve been talking about, who've been the leading weight loss stars for years, Mounjaro is set to steal the limelight with its dual action
Microdosing operates below those initiation thresholds